相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthetic immune niches for cancer immunotherapy
Jorieke Weiden et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Zinc oxide nanoparticles: a promising nanomaterial for biomedical applications
Pawan K. Mishra et al.
DRUG DISCOVERY TODAY (2017)
Silica Nanoparticle as a Lymph Node Targeting Platform for Vaccine Delivery
Myunggi An et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Targeting neoantigens to augment antitumour immunity
Mark Yarchoan et al.
NATURE REVIEWS CANCER (2017)
Cancer Neoantigens and Applications for Immunotherapy
Alexis Desrichard et al.
CLINICAL CANCER RESEARCH (2016)
Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication
Omar A. Ali et al.
CANCER IMMUNOLOGY RESEARCH (2016)
The host STING pathway at the interface of cancer and immunity
Leticia Corrales et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
Chao Wang et al.
NANO LETTERS (2016)
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
Danny N. Khalil et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Guiding Principles in the Design of Molecular Bioconjugates for Vaccine Applications
Haipeng Liu et al.
BIOCONJUGATE CHEMISTRY (2015)
Clinical Translation of Nanomedicine
Yuanzeng Min et al.
CHEMICAL REVIEWS (2015)
Synthetic Nanoparticles for Vaccines and Immunotherapy
Darrell J. Irvine et al.
CHEMICAL REVIEWS (2015)
In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf
Linda Hammerich et al.
MOLECULAR ONCOLOGY (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
In-situ tumor vaccination: Bringing the fight to the tumor
Robert H. Pierce et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
An overview of nanotoxicity and nanomedicine research: principles, progress and implications for cancer therapy
Ye Wang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2015)
Nanotoxicity: An Interplay of Oxidative Stress, Inflammation and Cell Death
Puja Khanna et al.
NANOMATERIALS (2015)
Nanoparticle-Based Immunotherapy for Cancer
Kun Shao et al.
ACS NANO (2015)
STING: infection, inflammation and cancer
Glen N. Barber
NATURE REVIEWS IMMUNOLOGY (2015)
Nanoparticles for Imaging, Sensing, and Therapeutic Intervention
Lara K. Bogart et al.
ACS NANO (2014)
Cryotherapy with Concurrent CpG Oligonucleotide Treatment Controls Local Tumor Recurrence and Modulates HER2/neu Immunity
Jesse J. Veenstra et al.
CANCER RESEARCH (2014)
Chemical Basis of Interactions Between Engineered Nanoparticles and Biological Systems
Qingxin Mu et al.
CHEMICAL REVIEWS (2014)
Intratumoral Immunization: A New Paradigm for Cancer Therapy
Aurelien Marabelle et al.
CLINICAL CANCER RESEARCH (2014)
Structure-based programming of lymph-node targeting in molecular vaccines
Haipeng Liu et al.
NATURE (2014)
Synthesis and surface functionalization of silica nanoparticles for nanomedicine
Alexander Liberman et al.
SURFACE SCIENCE REPORTS (2014)
Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
Michael Kalos et al.
IMMUNITY (2013)
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
Silvia C. Formenti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
Eleonore Froehlich
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Tumor-Cell Death, Autophagy, and Immunity
Louis M. Weiner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
VEGF-C Promotes Immune Tolerance in B16 Melanomas and Cross-Presentation of Tumor Antigen by Lymph Node Lymphatics
Amanda W. Lund et al.
CELL REPORTS (2012)
Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN
S. M. Geary et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors
Fernando Aranda et al.
CANCER RESEARCH (2011)
Toxicological considerations of clinically applicable nanoparticles
Lara Yildirimer et al.
NANO TODAY (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response
Haiyan Li et al.
NATURE NANOTECHNOLOGY (2011)
Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells
Sourav Bhattacharjee et al.
PARTICLE AND FIBRE TOXICOLOGY (2010)
Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy
Yuki Hor et al.
BIOMATERIALS (2009)
Understanding biophysicochemical interactions at the nano-bio interface
Andre E. Nel et al.
NATURE MATERIALS (2009)
Immunogenic and tolerogenic cell death
Douglas R. Green et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers
Pascale R. Leroueil et al.
NANO LETTERS (2008)
In situ tumor ablation creates an antigen source for the generation of antitumor immunity
MHMGM den Brok et al.
CANCER RESEARCH (2004)
Production of reactive oxygen species by mitochondria - Central role of complex III
Q Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
分享论文
